AFANWINGONG LAFON: Open Payments
NPI 1730565250 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 19 payments from 8 companies in 2025. Trend: 2023 $608 · 2024 $513 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: VRAYLAR, TRINTELLIX, COBENFY, Jornay PM, CAPLYTA, SPRAVATO, REXULTI, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
